Natus Medical today announced that it entered a definitive agreement to be acquired by Archimed for a total equity value of $1.2 billion. Through the agreement, Natus shareholders will receive $33.50 in cash for each share of Natus common stock to represent a 29% premium to the stock’s close price on April 14. “The sale […]
